Literature DB >> 6471672

Beneficial effect of thyroxin on recovery from toxic acute renal failure.

N J Siegel, K M Gaudio, L A Katz, H F Reilly, T A Ardito, F G Hendler, M Kashgarian.   

Abstract

To determine the effect of thyroxin (T4) on the recovery from toxic acute renal failure, rats were injected, subcutaneously, with K-dichromate (15 mg/kg) and at the peak of the renal injury, each animal was given either T4 (4 micrograms/100 g body weight, i.p.) or normal saline (NS). The T4-treated rats had significantly better CIn (669 +/- 35 microliter/min/100 g body weight), improved FENa (0.49 +/- 0.05%) and increased UOsm (835 +/- 50 mOsm/kg) as compared to animals given only NS (CIn 422 +/- 27; FENa 1.02 +/- 0.12; and UOsm 613 +/- 23). A similar dose of T4 given to non-injured control rats had no effect on renal function. The beneficial effect of T4 on dichromate injected rats was sustained and lead to more prompt recovery of glomerular function. To eliminate any hemodynamic effects of T4, an isolated perfused kidney preparation was utilized, and kidneys from dichromate injected rats treated with T4 had significantly better CIn, urine flow and FENa compared to rats given NS. Cellular morphology was better preserved in T4-treated animals. These data indicate that treatment with T4 results in enhanced recovery from an acute toxic renal insult and that this beneficial effect is unlikely to be related to nonspecific systemic effects of the hormone.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6471672     DOI: 10.1038/ki.1984.108

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

Review 1.  "Non-thyroidal illness syndrome" is functional central hypothyroidism, and if severe, hormone replacement is appropriate in light of present knowledge.

Authors:  L J DeGroot
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

Review 2.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

3.  Clinical quiz. Lesch-Nyhan syndrome.

Authors:  M M Bhagat; C J Reid
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

4.  Thyroxine prevents reoxygenation injury in isolated proximal tubule cells.

Authors:  Elif Erkan; Abdullah Sakarcan; Gonca Haklar; Suha Yalcin
Journal:  Pediatr Nephrol       Date:  2003-05-07       Impact factor: 3.714

Review 5.  Shedding and repair of renal cell membranes following drug-induced nephrotoxicity in humans.

Authors:  J E Scherberich; G Wolf; W Schoeppe
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 6.  New approaches to the treatment of acute renal failure.

Authors:  K M Gaudio; N J Siegel
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

7.  Beneficial effect of thyroxin in the treatment of ischemic acute renal failure.

Authors:  P M Sutter; G Thulin; M Stromski; T Ardito; K M Gaudio; M Kashgarian; N J Siegel
Journal:  Pediatr Nephrol       Date:  1988-01       Impact factor: 3.714

8.  Exogenous thyrotropin improves renal function in euthyroid patients, while serum creatinine levels are increased in hypothyroidism.

Authors:  Flore Duranton; Anouchka Lacoste; Patrick Faurous; Emmanuel Deshayes; Jean Ribstein; Antoine Avignon; Georges Mourad; Àngel Argilés
Journal:  Clin Kidney J       Date:  2013-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.